Secondary prevention in coronary heart disease

Coronary heart disease secondary prevention

Epidemiological data suggests that India is host to 30–40 million patients with coronary heart disease (CHD) and the 1 prevalence is increasing. This is also the largest cause of 2 mortality in the country. Unfortunately, the diagnosis and management of CHD in the country is not standardized and 3,4 follow-up mechanisms are poor. This is due to weak public and private healthcare systems for chr...

Secondary prevention of coronary heart disease in the elderly.

OBJECTIVE To review relevant literature supporting the use of aspirin, beta-blockers, lipid-lowering agents, and angiotensin-converting enzyme (ACE) inhibitors for the secondary prevention of coronary heart disease (CHD) in an elderly patient population aged >/=65 years. DATA SOURCES A MEDLINE search (1990-May 2003) was conducted using the key terms coronary heart disease, secondary preventio...

Primary and secondary prevention trials in coronary heart disease.

Secondary prevention of coronary heart disease in primary health care.

Significant increase in mortality from coronary heart disease (CHD) has been seen in Bosnia and Herzegovina in the past decade. Little is known about current secondary preventive practices and treatments among patients with CHD in primary health care. The aims of this study were to evaluate the components of secondary prevention for CHD and to detect possible gender differences. This trial incl...

Secondary prevention of coronary heart disease in elderly patients.

Coronary heart disease remains a leading cause of mortality in the United States, with 84 percent of persons 65 years or older dying from this disease. Secondary preventive measures, including lifestyle modification and pharmacotherapy, are important for elderly patients because of the variable impacts on morbidity and mortality rates and quality of life. Participating in light to moderate acti...